Determining ACE-2 Level and Some Relevant Biochemical Parameters and studying the effect of Gender in Iraqi Diabetic Patients with Glomeruli and Renal Tubules Fibrosis as Early Prediction Marker
Keywords:ACE-2, DKD, Diabetes Mellitus. Diabetic Nephropathy, Fibrosis, Gender effect
Diabetic kidney disease is an illness of the glomerulus that interferes with the glomerular filtration barrier (GFB), which is worked to enable kidney to selective purification of water and solutes in addition to limiting the movement of large macromolecules such as albumin. In the glomerular endothelium, mesangial cells, foot cells, and the brush border of the proximal tubules, ACE-2 is expressed and that the kidneys represent the highest-expressing region of this enzyme. Thus, the current study aimed to evaluate ACE-2 level in this case compared to healthy condition. The study Conducted with 120 male and female ranging in age (30-65) years old. Ninety patients with type 2 diabetes subdivided into three groups on the basis of ACR criteria including normoalbuminuria, microalbuminuria, macroalbuminuria (30 patients for each group) and 30 healthy people served as the control group, all visited Baghdad Teaching Hospital / Medical City and Al-Yarmouk Teaching Hospital, at the period between December 2021 and May 2022. ACE-2 levels were determined using the ELISA technique. Urea results showed significant differences between diabetic nephropathy in patient and control group in female cases but no significant differences in male patients with diabetic nephropathy and control group. Similar results were obtained in K ion. Also the results revealed significant differences in Na ion, ACR, eGFR, Urea, FBS, creatinine between diabetic nephropathy groups and healthy group.ACE-2 represents a good marker for early prediction in diabetic nephropathy case. ROC data analysis support the importance of ACE-2 in diagnosis of the studied disease case.
Received 16/9/2022, Revised 16/12/2022, Accepted 18/12/2022, Published Online First 20/4/2023
Zainab A Salman, Kadhim K Ghudhaib, Raghad Fadhil. Evaluating osteocalcin and ostenectin in serum male patients with type 2 diabetes mellitus and periodontitis. Eurasian Chem Commun. 2022; 16 (4): 295-302. https://dx.doi.org/10.22034/ecc.2022.325049.1307
Zainab A, Salman, Kadhim K Ghudhaib, Raghad Fadhil. Association of osteopontin and alkaline phosphatase in male patients with diabetes mellitus type 2 and periodontitis. Iran J War Public Health. 2022; 14(1): 105-109. https://dx.doi.org/10.30526/36.1.2924
Sabreen Ali Muzil, Kadhim K Ghudhaib, Ali Abdulmajid Dyab Allawi. Evaluation of pentraxin3 level in Iraqi patients with diabetic nephropathy. Biochem Cell Arch. 2018; 18(2): 2479-2482.
Sabreen Ali Muzil, Ali Abdulmajid Dyab Allawi, Kadhim K Ghudhaib. Determination of TNF1 level and its association with ACR and eGFR in Iraqi patients with different stages of diabetic nephropathy. Journal of Global Pharma Technology. 2018; 10 (05): 449-454.
Ghada salam Hamed, Kadhim K Ghudhaib, Ali A Allawi. Association of type IV collagen with progression of diabetic nephropathy disease in Iraqi patients under typical criteria. Arch. 2021; 21(1): 1471-1475.
Ghada Salam Hamid, Ali A Allawi, Kadhim K Ghudhaib. Correlation of Pentosidine with Kidney Diseases in Iraqi Patients with Diabetic Nephropathy. Iraqi J Sci. 2021; 30: 3436-42. https://dx.doi.org/10.24996/ijs.2021.62.10.2
Wahaj Sinan Mohammed, Kadhim K Ghudhaib, Ali A Allawi. Evaluation of Glomerular Disorder in Diabetic Patients with Nephropathy. Biochem Cell Arch. 2022; 22 (1): 963-969. https://dx.doi.org/10.3390/
Kadhim K Ghudhaib, Firas Younis Mohsen, Hind Sadiq Mohammed. Evaluation of Antioxidant Levels in Blood Sera of Iraqi Patients with T2DM. J Glob Pharma Technol. 2018; 10(3-4): 895-899
Hind Sadiq Mohammed, Kadhim K Ghudhaib, Firas Younis Mohsen. Estimation of enzymatic and non-enzymatic antioxidants in sera of Iraqi patients with sensory neuropathy. Biochem Cell Arch. 2018; 1 (18): 1011-1016. .
Tuka J, Khazeil, Kadhim K Ghudhaib, Firas Y. Mohsen. Assessment of levels of netrin-1 and adipsin in patients with diabetic peripheral neuropathy. Biochem Cell Arch. 2020; 20 (2): 6027-6032. DOI Zina J Ghaib, Kadhim K Ghudhiab, Firas Y. Mohsen. Assessment of Neuron Specific Enolase Level and some Related Biochemical Factors in Patients with Diabetic Peripheral Nerve Disorders. J Forensic Med Toxicol. 2021; 15 (3):1494-1500. https://dx.doi.org/10.37506/ijfmt.v15i3.15515
Marwa Nazar, Kadhim K. Ghudhaib, Firas Y. Mohsen. Evaluation of Nerve Growth Factor, Fetuin A and Adiponectin Levels in Diabetic Patients with Sensory Neuropathy. N L M. 2021; 10(1): 4103-4117.
Kadhim K Ghudhaib, Kismat, M.Turaki, Sabreen A Muzal. Estimation of Serum Osteocalcin Levels in Osteoporotic Postmenopausal Women with Type 2 Diabetes Mellitus. Iraqi J Sci. 2014 Sep-; 11 (4):1549-1555. https://dx.doi.org/10.1016/j.dsx.2018.04.035
Ghudhaib K, Turki K, Mezel S, Alzedi G, Alosami M. Association of Serum Adiponectin with Serum Insulin and Body mass density (BMD) in postmenopausal Osteoporotic women with and without T2DM. IOSR J Appl Chem. 2014; 7 (5): 119-122.. https://dx.doi.org/10.9790/5736-0752119122
Kadhim K Ghudhaib. Effect of alcoholic catechin extract on hyperglycemia, hyperlipidemia and liver functions in alloxan –diabetic mice. Iraqi J Sci. 2014;11(3):1192-200. https://dx.doi.org/10.21123/bsj.2014.11.3.1192-1200
Kadhim K Ghudhaib. Evaluation of Ginger Rhizomes Extract Effect on Glucose Level, Lipid Profile and Liver Function in Induced Alloxan Diabetic Mice. Res J Pharm Biol Chem Sci. 2018; 9(3): 435-441. 17.
Nakamura T, Girerd S, Jaisser F, Barrera-Chimal J. Mineralocorticoid receptor antagonists in diabetic kidney disease—Mechanistic and therapeutic effects. N L M. 2022; 18(1): 56-70. https://dx.doi.org/10.1038/s41581-021-00490-8
Xie H, Tong Q, Xiang Z, Zhou C, Wan LS, Chen J.Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway. Phytomedicine Plus. 2022;2(1):100152. https://dx.doi.org/10.1016/j.phyplu.2021.100152
Kaur G, Patney V. Progression of CKD and Uremic Symptoms. In Approaches to Chronic Kidney Disease. Springer Cham. 2022: 69-85. https://link.springer.com/chapter/10.1007/978-3-030-83082-3_5
Liu T, Chen J, Ying Y, Shi L, Chen Z. Inhibitory Effect of Gliquidone on Epithelial-to-Mesenchymal-Transition of Renal Tubular Epithelial Cells Under Diabetic Nephropathy Mouse Model. J Biomater Tissue Eng. 2022; 12(1): 71-80. https://dx.doi.org/10.3389%2Ffphar.2020.01136
Keelo RM, Elbe H, Bicer Y, Yigitturk G, Koca O, Karayakali M, et al. Treatment with crocin suppresses diabetic nephropathy progression via modulating TGF-β1 and oxidative stress in an experimental model of pinealectomized diabetic rats. Chem. Biol Interact. 2022Jan5;351:109733. https://dx.doi.org/10.1016/j.cbi.2021.109733
Xu Y, Fu EL, Trevisan M, Jernberg T, Sjolander A Clase C, et al. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. Am Heart J .2022; 243: 177-186. https://dx.doi.org/10.1016/j.ahj.2021.09.014
Pagliaro P, Thairi C, Alloatti G, Penna C.. Angiotensin-converting enzyme 2: a key enzyme in key organs. J Cardiol. 2022; 23(1): 1-11. https://dx.doi.org/10.2459/jcm.0000000000001218
Chen S, Redfors B, Serruys PW, Kappetein AP, Crowley A, Yehuda O, et al. Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease. Coron Artery Dis. 2022; 31(1): 37-44. https://dx.doi.org/10.1002/phar.2624
Wysocki J, Ortiz‐Melo DI, Mattocks NK, Xu K, Prescott J, et al. ACE 2 deficiency increases NADPH‐mediated oxidative stress in the kidney. Physiol Rep. 2014; 2(3): e00264. https://dx.doi.org/10.1002%2Fphy2.264
Forthofer RN, Lee ES. Introduction to biostatistics: a guide to design, analysis, and discovery. Elsevier; Academic press, Inc. 2014 May 19. https://books.google.com/books?hl=en&lr=&id=CsvNBQAAQBAJ
Yamamoto Y, Hanai K, Mori T, Yokoyama Y, Yoshida N,et al. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency. Diabetologia. 2022; 65(1): 234-245. https://dx.doi.org/10.1007/s00125-021-05590-5
Mohammed E, Al Salmi I, Al Riyami D, Khan S, Al Riyami M,et al. Non-Diabetic Kidney Disease in Type 2 Diabetes Mellitus: A Study of 82 Patients and Review of the Literatures. Open J Nephrol. 2022; 12(1):169-186. https://dx.doi.org/10.4236/ojneph.2022.121017
Gluba-Brzózka A, Rysz J, Franczyk B, Banach M. Dyslipidemia and Diabetes. InDiabetes and Kidney Disease. Springer, Cham. 2022: 341-360. https://link.springer.com/chapter/10.1007/978-3-030-86020-2_15.
Kautzky‐Willer A, Kosi L, Lin J, Mihaljevic R. Gender‐based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient‐level pooled data of six randomized controlled trials. Diabetes Obes Metab. 2015; 17(6): 533-540. https://dx.doi.org/10.1007/978-3-030-86020-2
Carlström, M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol.2021;17(9):575-590. https://dx.doi.org/10.1038/s41581-021-00429-z
Ahmed SB, Fisher ND, Hollenberg NK. Gender and the renal nitric oxide synthase system in healthy humans. J Am Soc Nephrol. 2007; 2(5): 926-931. https://dx.doi.org/10.2215/cjn.00110107
Aljack HA. Albumin. Creatinne Ratio as Predictor Markers for Nephropathy in Sudanese Type 2 Diabetic Patients. Sudan Med J. 2018; 6(1). https://dx.doi.org/10.18502/sjms.v14i3.5213
Aljack HA. High sensitive c reactive protein as predictor marker for cardiovascular diseases in Sudanese type 2 diabetic patients. Sudan Med J. 2019; 14(3): 132-142. https://dx.doi.org/10.18502/sjms.v14i3.5213
Mohammed-Ali Z, Lu C, Marway MK, Carlisle RE, Ask K, Lukic D, et al. Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria. Sci. Rep. 2017; 7(1): 1-14. https://dx.doi.org/10.1038/srep41572
Otani N, Ouchi M, Misawa K, Hisatome I, Anzai N.Hypouricemia and Urate Transporters. Biomedicines..2022; 10(3): 652. https://dx.doi.org/10.3390/biomedicines10030652
Iocca A, Bardwell A, Schumacher J, Barnes J. Ice-cream substitute for patients with kidney failure. J Ren Nurt. 2022 Jan; 32(2): 207-213. https://dx.doi.org/10.1053/j.jrn.2021.02.002
Ferrario CM, Groban L, Wang H, Sun X, VonCannon JL, Wright KN, Ahmad S.. The renin–angiotensin system biomolecular cascade: a update of newer insights and concepts. Kidney Int Suppl. 2022; 12(1): 36-47. https://dx.doi.org/10.1016/j.kisu.2021.11.002
Nakayama T, Morimoto K, Uchiyama K, Kusahana E, et al. Effects of renin-angiotensin system inhibitors on the incidence of unplanned dialysis. Am J Hypertens . 2022; 45(6): 1018- 27. https://dx.doi.org/10.1038/s41440-022-00877-5
Bovée DM, Uijl E, Severs D, Rubio-Beltrán E, van Veghel R, et al. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease Am. J Physiol Renal Physiol , https://dx.doi.org/10.1152/ajprenal.00603.2020
DeFronzo RA, Bakris GL. Bakris. Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes. Diabetes Obes Metab. 2022; 24: 1197–1205. https://dx.doi.org/10.1111/dom.14696
Golosova D, Levchenko V, Kravtsova O, Palygin O, Staruschenko A. Acute and long-term effects of cannabinoids on hypertension and kidney injury Sci Rep. 2022; 12(1): 1-12. https://dx.doi.org/10.1038/s41598-022-09902-6
Mizdrak M, Kumric M, Kurir T, Bozik J. Emerging Biomarkers for Early Detection of Chronic Kidney Disease. J Pers Med. 2022; 12(4): 548. https://dx.doi.org/10.3390%2Fjpm12040548
Ryuzaki M, Miyashita K, Sato M, Inoue H, Fujii K, et al. Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats. J hypertens. 2022; 40(1): 33-45. https://dx.doi.org/10.1097/hjh.0000000000002974
Arefin S, Hernandez L, Ward L, Stenvinkel P, Kublickiene K. MO069 SARS-COV-2 receptor ACE-2, TMPRSS2 and soluble ACE-2 in patients with end stage kidney disease. Nephrol Dial.2021; 36(1): 078- 005.https://dx.doi.org/10.1093%2Fndt%2Fgfab078.005
Khurana Vatsala, Goswami Binita. Angiotensin converting enzyme (ACE). Clin. Chim. Acta. 2022; 524: 113- 122. https://dx.doi.org/10.1016/j.cca.2021.10.029
Erpolat OP, Senturk E, Saribas S, Pasinlioglu B, Gulbahar O,et al. Angiotensin-converting enzyme inhibitor reduces radiation-induced periprosthetic capsular fibrosis. J Surg Res. 2021; 263: 167-175. https://dx.doi.org/10.1016/j.jss.2021.01.033
Al-Hassnawi AT, Al-Morshidy KA, Al-Harbi NY. Milk Tumor Necrosis Factor Alpha and Interleukin-1Beta Among Toxoplasma gondii-Free and Infected Women. Baghdad Sci J. 2022;19(1): 0001-0006. https://dx.doi.org/10.21123/bsj.2022.19.1.0001
Ma K, Gao W, Xu H, Liang W, Ma G. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. J Renin Angiotensin Aldosterone Syst. 2022 jan 24; 2022. https://dx.doi.org/10.1155/2022/3239057
Nomura H, Kuruppu S, Rajapakse NW.Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy. Front physiol.2022:2497. https://dx.doi.org/10.3389/fphys.2021.813012
Khidhir SM, Mahmud AM, Maulood IM. Association of Endothelin-I and A symmetric Dimethylarginine Levels with Insulin Resistance in Type-2 Diabetes Mellitus Patients. Baghdad Sci J. 2022; 19(1): 0055-0063. https://dx.doi.org/10.21123/bsj.2022.19.1.0055
Copyright (c) 2023 Baghdad Science Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.